Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 53 results for "biocon under kiran mazumdar shaw"

Kiran Mazumdar-Shaw to debut an Art and Science Exhibition at Ser...
India Blooms

Kiran Mazumdar-Shaw to debut an Art and Science Exhibition at ...

Kolkata/New Delhi, Dec 9 (IBNS): 2016: Biocon's Chairperson and Managing Director Kiran Mazumdar-Shaw is enabling the showcase of a special exhibition of Science Gallery Bengaluru, Entanglement: A Dance between Art & Science at the Serendipity Arts ... India Blooms, 1 day ago

54 images for biocon under kiran mazumdar shaw

Livemint.com, 1 week ago
Yahoo! India, 4 days ago
International Business Times India, 4 days ago
Financial Express, 2 weeks ago
Money Control, 2 weeks ago
Indian Express, 1 month ago
Indian Express, 1 month ago
Business Today India, 1 month ago
Livemint.com, 2 months ago
Livemint.com, 2 months ago
Livemint.com

Kiran Mazumdar-Shaw silences her Twitter trolls with a 78% stock rally

It was the best return among shares of generic drugmakers worldwide For more than two years, Kiran Mazumdar-Shaw had a quarterly date with her Twitter trolls. Every three months, after her Bengaluru-based pharmaceutical company would deliver its ...
 Business Standard India1 week ago Kiran Mazumdar-Shaw shuts up her Twitter trolls with Biocon stock rally  Livemint.com1 week ago How One Woman Shut Up Twitter Trolls With Pharma Stock Rally (1)  Yahoo! Singapore1 week ago Kiran Mazumdar-Shaw silences Twitter trolls with a 78% Biocon stock rally  Smart Investor1 week ago
Financial Express

Demonetisation to help leapfrog to digital economy: Biocon CMD

HYDERABAD: Biotech entrepreneur Kiran Mazumdar-Shaw has said the demonetisation of high-value currency notes is an opportunity to leapfrog into a digital cashless economy, even as she called for a effective monitoring to prevent accumulation of ...
 Economic Times2 weeks ago
Forbes India

Affordable healthcare tech startups get backing from Mazumdar-Shaw, Healthquad

Beyond the urban household, India's poor are in dire need of access to health care, and these startups are tackling the challenge Image: Shutterstock Neurosynatpic has built a patented digital health solution — a combination of software ...
 Forbes India1 month ago
Siasat Daily

Stocks in focus: RIL, Biocon

Shares of Reliance Industries today fell 2.5 per cent after the company reported 23 per cent decline in second quarter net profit. The stock, even after a positive opening, failed to hold on to the gains and slipped 2.51 per cent to Rs 1,061.10 on ...
 Hindu Business Line1 month ago Biocon net up 52% in second quarter  Yahoo! India1 month ago Biocon Q2 net profit of Rs 146.7 cr  Moneycontrol.com1 month ago Biocon profit up 52% to Rs.147 crore in Q2  Livemint.com1 month ago
[x]  
Livemint.com

Biocon says first set of biosimilars to hit European market by early 2018

The firm, along with Mylan NV, is developing four biosimilars: pegfilgrastim, trastuzumab, adalimumab and insulin glargine Hyderabad: Bio-pharmaceutical company Biocon Ltd on Friday said it expects to see its first set of biosimilar products hit the ...
 Livemint.com1 month ago

Edited Transcript of BIOCON.NSE earnings conference call or presentation 21-Oct-16 3:30am GMT

Half Year 2017 Biocon Ltd Earnings Call TEXT version of Transcript ================================================================================ Corporate Participants ...
 Yahoo! Finance1 month ago

Biocon hits record high on strong Q2 earnings

Biocon's facility. Photo: Company's website Biocon hit a fresh record high of Rs 1,020, up 4% on BSE in early morning trade, after the company posted robust 52% year on year (YoY) jump in consolidated net profit at Rs 147 crore for the quarter ...
 Smart Investor1 month ago

Biocon Q2 FY17 Revenue Up 21% EBITDA Up 45% Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.

Biocon Ltd (BSE code: 532523, NSE: BIOCON), Asia's premier biopharmaceuticals company, announced today its consolidated financial results for the second quarter ended on September 30th, 2016. Commenting on the quarterly performance and highlights, ...
 Biocon1 month ago Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%  Businessworld India1 month ago Biocon Q2 FY17 Revenue Up 21 EBITDA Up 45  Pharma Focus Asia1 month ago
[x]  

KM Shaw invests in UE LifeSciences, developer of affordable breast cancer screening devices

UE LifeSciences, a mobile health technology developer of iBreastExam, has raised follow-on strategic investment of $1.2 million (approximately Rs 8 crore) led by Kiran Mazumdar-Shaw, Chairman and Managing Director of Biocon. Its existing investor ...
 Yourstory.in2 months ago UE LifeSciences raises $1.2 mn to scale up operations in India & expand innovation pipeline in mobile health devices segment  PharmaBiz2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less